Pacific Biosciences of California Inc

2026. okt. 21. 23:16 UTC

Pacific Biosciences of California Inc is trading modestly higher in after-market hours, marking its fifth consecutive session of gains.

2026. okt. 20. 23:16 UTC

Pacific Biosciences of California Inc is trading modestly higher in after-market hours following Tuesday's close, amid ongoing volatility within its one-month trading range.

2026. okt. 19. 20:07 UTC

Pacific Biosciences announces a multi-year collaboration with Verily Health to integrate HiFi sequencing technology with Verily's AI platform for clinico-genomic datasets.

2026. okt. 16. 23:06 UTC

Pacific Biosciences of California Inc is effectively unchanged in after-market trading, having retraced from earlier highs amid recent declines below its 20-day moving average.

2026. okt. 15. 23:02 UTC

After-market hours, the ARK Genomic Revolution ETF (ARKG) is trading higher, supported by a Neutral rating for CRISPR Therapeutics from UBS and gains in key holdings.

2026. okt. 14. 23:21 UTC

Pacific Biosciences shares declined in after-market trading, marking the fourth consecutive session of lower prices, reaching a recent low shortly before the latest timestamp.

2026. okt. 13. 23:06 UTC

Pacific Biosciences of California Inc's shares were roughly flat in after-market trading, following three consecutive lower daily closes while remaining above the 20-day moving average.

2026. okt. 12. 22:16 UTC

Pacific Biosciences of California Inc is trading roughly flat in after-market hours, with the stock positioned around the middle of its one-month range.

2026. okt. 9. 20:07 UTC

UBS initiated coverage of Pacific Biosciences with a Neutral rating and a price target of $1.35, adjusting its Fair Value estimate to $2.40 per share.

2026. okt. 8. 23:20 UTC

Pacific Biosciences shares declined significantly in after-market trading, reversing earlier gains and marking a notable drop compared to Thursday's close.

2026. okt. 7. 23:06 UTC

Pacific Biosciences of California Inc declined during after-market hours on Wednesday, retracing significantly from its prior close despite strong recent performance.

2026. okt. 6. 23:06 UTC

Pacific Biosciences of California Inc declined in after-market trading, moving lower since Tuesday's close, despite strong performance over the past month.

2026. okt. 5. 20:03 UTC

Pacific Biosciences of California Inc is higher in Monday's trading, continuing its upward trend since Friday, despite earlier pulling back from a session high.

2026. okt. 2. 20:00 UTC

Pacific Biosciences of California Inc is trading higher on Friday, maintaining gains above its 20-day moving average despite a recent pullback.

2026. okt. 1. 23:05 UTC

Pacific Biosciences of California Inc's shares showed little change in after-market trading, remaining near Thursday's close after a brief uptick.

2026. szept. 30. 23:01 UTC

Pacific Biosciences of California Inc declined sharply in after-market trading, contrasting with its recent upward trend, but remains above its 20-day moving average.

2026. szept. 29. 23:16 UTC

Pacific Biosciences of California Inc's shares are trading lower in after-market hours, retracing from a flat position since Tuesday's close.

2026. szept. 28. 20:07 UTC

Pacific Biosciences of California Inc is advancing, reflecting broader market gains since Friday, despite pulling back from a session high earlier today.

2026. szept. 25. 23:51 UTC

Pacific Biosciences of California Inc is trading lower in after-market hours, reflecting a notable decline since Friday's close and today's sharp loss.

2026. szept. 24. 23:01 UTC

Pacific Biosciences of California Inc is declining in after-market trading, falling significantly from Thursday's close, despite being above its 20-day moving average.

2026. szept. 23. 20:07 UTC

Pacific Biosciences is sharply lower, following a broader market decline and significant losses in key holdings of the ARK Genomic Revolution ETF.

2026. szept. 22. 23:06 UTC

Pacific Biosciences of California Inc is trading lower in after-market hours, having declined from earlier gains and remaining above its 20-day moving average.

2026. szept. 21. 22:35 UTC

In after-market trading, Pacific Biosciences of California Inc is roughly flat since Monday's close, reflecting routine performance near the lower end of its one-month range.

2026. szept. 18. 23:51 UTC

Pacific Biosciences of California Inc declined during after-market trading, moving lower since Friday's close and currently below its 20-day moving average.

2026. szept. 17. 20:02 UTC

Pacific Biosciences is sharply higher, reflecting a positive trend in the life sciences sector, alongside gains in the ARK Genomic Revolution ETF.

2026. szept. 16. 23:16 UTC

Pacific Biosciences of California Inc is trading roughly flat in after-market hours, remaining below its 20-day moving average after four consecutive higher sessions.

2026. szept. 15. 23:11 UTC

Pacific Biosciences of California is gaining in after-market trading, supported by a positive performance backdrop and four consecutive higher closes.

2026. szept. 14. 20:05 UTC

Pacific Biosciences of California is higher today, influenced by social media discussions on Tempus AI's $80 price target and broader market sentiment.

2026. szept. 11. 19:02 UTC

Pacific Biosciences of California is trading higher, continuing its recovery after three sessions of declines. No specific news was identified for the upward movement.

2026. szept. 9. 20:01 UTC

Pacific Biosciences of California shares are lower after UBS initiated coverage with a Neutral rating and a price target of $1.35.